|
|
Cdc42bpg signaling in arteriosclerosis and vascular fibrosis |
| 1R03TR004144-01 |
|
NCATS |
2022 |
|
|
Elucidating the roles of CACNA2D2 and CACNA2D3 in presynaptic regulation of mammalian synaptic function |
| 1R03TR004161-01 |
|
NCATS |
2022 |
|
|
Fiber design and assessment for development of a novel biomimetic medical device |
| 5R44TR001324-04 |
|
NCATS |
2022 |
|
|
Decoding Selective Vulnerability: Effectors and Regulators of Tau Lesion Spread in Alzheimers Disease |
| 1F30AG072804-01A1 |
|
NIA |
2022 |
|
|
Behavioral, molecular, and functional dissection of corticospinal neurons in motor performance deficits of physiological and pathological aging |
| 1F30AG074598-01A1 |
|
NIA |
2022 |
|
|
Development of a Novel PET Tracer for Imaging Microglial Function in Alzheimers Disease |
| 1F30AG074633-01A1 |
|
NIA |
2022 |
|
|
The role of mitochondrial fission in neurodegeneration in the leading environmental cause of Alzheimers disease |
| 1F30AG076183-01A1 |
|
NIA |
2022 |
|
|
Uncharted Territory: Mapping and Manipulating Cholinergic Basal Forebrain Activity in a Mouse Model of Alzheimers Disease |
| 1F30AG076265-01A1 |
|
NIA |
2022 |
|
|
Treatment of Alzheimer’s Disease using Ultrasound-Targeted Microbubble Cavitation-Mediated Blood Brain Barrier Opening to Facilitate Drug Delivery to the Brain |
| 1F30AG077800-01 |
|
NIA |
2022 |
|
|
Neurophysiological Basis for Functional Connectivity Changes in Early Alzheimer’s Disease |
| 1F30AG079507-01 |
|
NIA |
2022 |
